WASHINGTON — Over vehement objections by drug companies, the Trump administration proposed on Monday a new federal regulation that would require them to disclose the list prices of prescription drugs in their television advertisements.
The proposal sets the stage for a battle with the pharmaceutical industry, which said the requirement would be a form of “compelled speech” in violation of the First Amendment.
